Generic azacitidine tablet tested against Brand-Name onureg in AML patients
Disease control
Completed
This study compared a generic azacitidine tablet to the brand-name drug Onureg in 32 adults with acute myeloid leukemia (AML) who are in remission. Participants took a single dose of each drug under fasting conditions to see if the generic version is absorbed similarly. The goal …
Phase: PHASE1 • Sponsor: Hikma Pharmaceuticals LLC • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC